Form 4: Calumet Director Paul Raymond Receives 3,796 Restricted Stock Units

Calumet, Inc. Director Paul C. Raymond was granted 3,796 restricted stock units (RSUs) on June 9, 2025, as disclosed in a recent SEC Form 4 filing.

Summary

• Paul C. Raymond, a Director of Calumet, Inc. (CLMT), acquired 3,796 Restricted Stock Units (RSUs) on June 9, 2025.
• Each RSU is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
• The acquired RSUs are 100% vested and will be settled upon vesting.
• Following this transaction, Mr. Raymond directly beneficially owns 3,796 derivative securities (RSUs).
• A Power of Attorney, executed on June 10, 2025, appoints L. Todd Borgmann, David A. Lunin, Gregory J. Morical, John R. Krutz, and Connor J. Egan as attorneys-in-fact for Paul C. Raymond III.
• The Power of Attorney authorizes the attorneys-in-fact to prepare, execute, and file SEC Forms 3, 4, 5, and 144 on behalf of Mr. Raymond, and to manage his EDGAR account for electronic filings.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the RSU grant aligns the director's interests with shareholders, a common and generally well-regarded practice in corporate governance. It is a routine transaction and not indicative of significant operational changes.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The RSUs are 100% vested, indicating immediate ownership rights upon grant, which can be seen as a positive for the recipient.

Future Outlook

The document does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider's equity transaction.

Industry Context

The grant of Restricted Stock Units is a common form of equity compensation for directors and executives across various industries, used to align their interests with long-term shareholder value. This filing is a routine disclosure of such an event.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant increases the director's equity stake, potentially strengthening alignment between the director's financial interests and the company's stock performance, which could benefit shareholders in the long term.

Next Steps

• The Restricted Stock Units will be settled upon vesting, converting into shares of Calumet, Inc. common stock.

Key Dates

Keywords

Calumet, CLMT, SEC Form 4, Insider Transaction, Restricted Stock Unit, RSU, Director Compensation, Equity Grant, Corporate Governance, Power of Attorney